Suchergebnisse - (Subject:"lopinavir")

PubPharm (235)

11

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19 : final results

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Ader, F. | DisCoVeRy Study Group

12

Emerging Therapies for COVID-19 : The Value of Information From More Clinical Trials

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2022

von Dijk, S. | Krijkamp, E. | Kunst, N. | +3

13

High-cited favorable studies for COVID-19 treatments ineffective in large trials

enthalten in: Journal of clinical epidemiology | 2022

von Ioannidis, J.

14

Presentation and outcomes of chronic kidney disease patients with COVID-19

enthalten in: Jornal brasileiro de nefrologia | 2022

von Branco, C. | Duarte, I. | Gameiro, J. | +8

15

Off-Label Use of Hydroxychloroquine in COVID-19 : Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance

enthalten in: Journal of clinical pharmacology | 2022

von Fallani, E. | Cevenini, F. | Lazzerini, P. | +2

16

Safety profile of COVID-19 drugs in a real clinical setting

enthalten in: European journal of clinical pharmacology | 2022

von Chiu, M. | Bhardwaj, M. | Sah, S.

17

Remdesivir and three other drugs for hospitalised patients with COVID-19 : final results of the WHO Solidarity randomised trial and updated meta-analyses

enthalten in: Lancet (London, England) | 2022

von WHO Solidarity Trial Consortium | Pan, H. | Peto, R. | +98

CommentIn: Lancet. 2022 May 21;399(10339):1918-1920. - PMID 35512729

18

Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels

enthalten in: International journal of molecular sciences | 2022

von Caufriez, A. | Tabernilla, A. | Van Campenhout, R. | +8

19

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19 : meta-epidemiological study

enthalten in: BMJ (Clinical research ed.) | 2022

von Moneer, O. | Daly, G. | Skydel, J. | +4

20

QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs

enthalten in: Anales de pediatria | 2022

von Esmel-Vilomara, R. | Dolader, P. | Sabaté-Rotes, A. | +3